MyAverix Finance
HK · Healthcare
Canbridge Pharmaceuticals Inc (1228)
Biotechnology
Canbridge Pharmaceuticals Inc (1228) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $1.04B, P/E ratio is 68.00, net margin is 29.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1228
Canbridge Pharmaceuticals Inc (1228) — FAQ
What is Canbridge Pharmaceuticals Inc's market cap?
Canbridge Pharmaceuticals Inc (1228) has a reported market cap of $1.04B (data as of 2026-05-21).
What is 1228's P/E ratio?
The price-to-earnings (P/E) ratio for Canbridge Pharmaceuticals Inc (1228) is 68.00 (data as of 2026-05-21).
Does Canbridge Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for Canbridge Pharmaceuticals Inc (1228). Check the MyAverix Finance app for the latest dividend data.
What sector is Canbridge Pharmaceuticals Inc in?
Canbridge Pharmaceuticals Inc (1228) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1228 listed on?
1228 is listed on HK.
What is Canbridge Pharmaceuticals Inc's net margin?
Canbridge Pharmaceuticals Inc (1228) reports a net margin of 29.7% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.